The India business, accounting for a third of the company’s total revenues, grew at 11%. This is a volume-led growth aided by new product launches. Sun’s India business grew higher than the Indian Pharma market growth. The company launched 14 new products during the quarter.
Healthy loan growth, fall in provisions spruce up SBI Q3
Unlike a year ago, SBI did not have to make a ₹7,100-crore provision for employee pension and wages, boosting profit growth at the country’s most-valued
February 7, 2025